相关实验视频

Updated: Jul 12, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

针对肺部威胁剂的对策

Jacqui Marzec¹, Srikanth Nadadur²

¹National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.

The Journal of pharmacology and experimental therapeutics

|October 20, 2023

概括

吸入的有毒物质,包括化学战剂和工业化学品,对急性肺损伤和长期呼吸道并发症构成重大风险. 对大规模伤亡事件制定有效的对策至关重要.

科学领域:

环境健康环境健康
毒理学毒理学毒理学
肺部医学肺部医学

背景情况:

吸入的有毒物质,从工业化学品到化学战剂 (CWA),是越来越令人担忧的,因为它们可能导致严重的呼吸道并发症.
历史上和最近使用CWA,以及工业/农业化学品带来的风险,强调需要了解急性吸入毒性.
目前的紧急治疗仅限于支持性护理,强调需要先进的治疗策略.

研究的目的:

审查当前对精选吸入化学威胁的急性毒性和病理生理学的理解.
讨论吸入有毒物质引起的肺损伤的潜在早期治疗发展.
识别开发针对涉及吸入化学物质暴露的大规模伤亡情况的对策的挑战.

主要方法:

本小小的综述综合了当前有关吸入毒素的毒理学和病理生理学的知识.
它检查了各种化学物质暴露导致的肺损伤的临床进展.
该审查讨论了现有和潜在的治疗干预措施和对策的发展.

主要成果:

对工业刺激剂和CWA的急性暴露可能会导致立即的呼吸困扰,进展到急性肺损伤 (ALI) 和急性呼吸困扰综合征 (ARDS).
延迟并发症包括阻塞性肺病和肺纤维化,需要长期的临床管理.
对急性吸入伤害的有效治疗方法仍然有限,这强调了需要新的治疗方法的需要.

结论:

吸入的化学威胁在民用和军事环境中构成重大和日益增长的风险.
迫切需要制定有效的对策,以减轻急性肺损伤和随后的慢性呼吸道疾病.
进一步研究早期治疗和大规模管理策略对于应对这些威胁至关重要.

更多相关视频

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

相关概念视频

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.